Points to consider in the evaluation of biopharmaceuticals

Irene Kraemer, Roger Tredree, Arnold G. Vulto

Research output: Contribution to journalArticleAcademic

Abstract

The pharmacist, as the medicines expert, should be able to assess the quality and safety of a biopharmaceutical and needs to know which criteria to use for the evaluation. A checklist incorporates the regulatory requirements and gives guidance when choosing biopharmaceuticals and biosimilars.
Original languageEnglish
Pages (from-to)73-76
Number of pages4
JournalEJHP Practice
Volume14
Issue number1
Publication statusPublished - 2008

Research programs

  • EMC OR-01-34-01

Fingerprint

Dive into the research topics of 'Points to consider in the evaluation of biopharmaceuticals'. Together they form a unique fingerprint.

Cite this